California State Teachers Retirement System (CalSTRS)’s Kalaris Therapeutics KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-364
Closed -$5.7K 3060
2023
Q4
$5.7K Sell
364
-2,087
-85% -$82.3K ﹤0.01% 3045
2023
Q3
$121K Sell
2,451
-325
-12% -$22.1K ﹤0.01% 2560
2023
Q2
$217K Buy
2,776
+498
+22% +$47.3K ﹤0.01% 2539
2023
Q1
$206K Sell
2,278
-18
-0.8% -$2.29K ﹤0.01% 2568
2022
Q4
$271K Buy
2,296
+26
+1% +$4.41K ﹤0.01% 2556
2022
Q3
$412K Buy
2,270
+518
+30% +$80.7K ﹤0.01% 2415
2022
Q2
$157K Sell
1,752
-122
-7% -$12.8K ﹤0.01% 2739
2022
Q1
$291K Sell
1,874
-140
-7% -$27.9K ﹤0.01% 2573
2021
Q4
$599K Buy
2,014
+43
+2% +$19.9K ﹤0.01% 2443
2021
Q3
$1.14M Buy
1,971
+203
+11% +$94K ﹤0.01% 2068
2021
Q2
$803K Sell
1,768
-173
-9% -$89.3K ﹤0.01% 2356
2021
Q1
$1.04M Buy
1,941
+762
+65% +$640K ﹤0.01% 2122
2020
Q4
$1.04M Hold
1,179
﹤0.01% 2013
2020
Q3
$746K Buy
+1,179
New +$805K ﹤0.01% 2041

Other funds holding KLRS

California State Teachers Retirement System (CalSTRS)'s KLRS Position: Q1 2024 in Review

California State Teachers Retirement System (CalSTRS) sold out of Kalaris Therapeutics (KLRS) in Q1 2024, closing a stake of 364 shares — an estimated $5.7K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in KLRS in Q3 2020 and held it in 14 quarters. The position peaked at $1.14M in Q3 2021. 76 funds tracked by Wall St. Rank hold KLRS as of Q1 2024.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Kalaris Therapeutics position as of Q1 2024 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 364 Kalaris Therapeutics shares in Q1 2024, an estimated $5.7K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Kalaris Therapeutics in Q3 2020 and held it in 14 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Kalaris Therapeutics position peaked at $1.14M in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2024.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2024, filed 16 May 2024.